New Drug Prolia Approved, Helps Fight Osteoporosis
Women of the Chinese ruling class once had little weight-bearing their entire lives, and the bone conditions they found themselves in were appalling. But modern life has hardly made progress worldwide as inadequate diet, exercise and genetic predisposition leaves too many of us with inadequate bone strength as we age.
The "silent epidemic," osteoporosis, is increasing in significance as the population of the world both increases and ages, and the World Health Organization (WHO) has identified this as a priority health issue.
Statistics vary, but one set says that, of an estimated 9 million new osteoporotic fractures globally in 2000, 1.7 million were at the forearm, 1.6 million were at the hip, and 1.4 million were clinical (symptomatic) fractures of the vertebrae in the backbone.
A new strategy was just approved in Europe and now has come to the US; Amgen corporation brings us a biologic treatment called Prolia. It's approved, but not yet on the shelves: more will be coming about this exciting treatment indicated for women with osteoporosis who are at a high risk for fracture. Stand tall, take your calcium, get Vitamin D in, and get your bone density checked.
We need some facts, as the drug will cost you about $1500 or $1600/year, versus generic Fosamax, which is about $20/month. Stay tuned for more facts, and read the other posts about bone health.